Positron has entered into an exclusive sales and marketing agent agreement with NuView Radiopharmaceuticals.
Subscribe to our email newsletter
NuView Radiopharmaceuticals will act as exclusive agent for Positron’s brand of Pet, Spect and automated dose dispensing systems.
Paul Crowe, CEO of NuView, said: “We’re very pleased to have been selected by Positron to represent their automated dose drawing, Spect and Pet diagnostic imaging technologies in the US. The Pet devices small footprint makes it the ideal system for private offices or clinic settings.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.